Cookies

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this repository, you give consent for essential cookies to be used. You can read more about our Privacy and Cookie Policy.


Durham Research Online
You are in:

Retinal structure and function in achromatopsia : implications for gene therapy.

Sundaram, V. and Wilde, C. and Aboshiha, J. and Cowing, J. and Han, C. and Langlo, C.S. and Chana, R. and Davidson, A.E. and Sergouniotis, P.I. and Bainbridge, J.W. and Ali, R.R. and Dubra, A. and Rubin, G. and Webster, A.R. and Moore, A.T. and Nardini, M. and Carroll, J. and Michaelides, M. (2014) 'Retinal structure and function in achromatopsia : implications for gene therapy.', Ophthalmology., 121 (1). pp. 234-245.

Abstract

Purpose: To characterize retinal structure and function in achromatopsia (ACHM) in preparation for clinical trials of gene therapy. Design: Cross-sectional study. Participants: Forty subjects with ACHM. Methods: All subjects underwent spectral domain optical coherence tomography (SD-OCT), microperimetry, and molecular genetic testing. Foveal structure on SD-OCT was graded into 5 distinct categories: (1) continuous inner segment ellipsoid (ISe), (2) ISe disruption, (3) ISe absence, (4) presence of a hyporeflective zone (HRZ), and (5) outer retinal atrophy including retinal pigment epithelial loss. Foveal and outer nuclear layer (ONL) thickness was measured and presence of hypoplasia determined. Main Outcome Measures: Photoreceptor appearance on SD-OCT imaging, foveal and ONL thickness, presence of foveal hypoplasia, retinal sensitivity and fixation stability, and association of these parameters with age and genotype. Results: Forty subjects with a mean age of 24.9 years (range, 6e52 years) were included. Disease-causing variants were found in CNGA3 (n [ 18), CNGB3 (n ¼ 15), GNAT2 (n ¼ 4), and PDE6C (n ¼ 1). No variants were found in 2 individuals. In all, 22.5% of subjects had a continuous ISe layer at the fovea, 27.5% had ISe disruption, 20% had an absent ISe layer, 22.5% had an HRZ, and 7.5% had outer retinal atrophy. No significant differences in age (P ¼ 0.77), mean retinal sensitivity (P ¼ 0.21), or fixation stability (P ¼ 0.34) across the 5 SD-OCT categories were evident. No correlation was found between age and foveal thickness (P ¼ 0.84) or between age and foveal ONL thickness (P ¼ 0.12). Conclusions: The lack of a clear association of disruption of retinal structure or function in ACHM with age suggests that the window of opportunity for intervention by gene therapy is wider in some individuals than previously indicated. Therefore, the potential benefit for a given subject is likely to be better predicted by specific measurement of photoreceptor structure rather than simply by age. The ability to directly assess cone photoreceptor preservation with SD-OCT and/or adaptive optics imaging is likely to prove invaluable in selecting subjects for future trials and measuring the trials’ impact.

Item Type:Article
Full text:(AM) Accepted Manuscript
Download PDF
(2133Kb)
Status:Peer-reviewed
Publisher Web site:https://doi.org/10.1016/j.ophtha.2013.08.017
Publisher statement:NOTICE: this is the author’s version of a work that was accepted for publication in Ophthalmology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Ophthalmology, 121, 1, January 2014, 10.1016/j.ophtha.2013.08.017.
Date accepted:13 August 2013
Date deposited:02 March 2016
Date of first online publication:19 October 2013
Date first made open access:No date available

Save or Share this output

Export:
Export
Look up in GoogleScholar